These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 26129649)
1. The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients. Allers K; Puyskens A; Epple HJ; Schürmann D; Hofmann J; Moos V; Schneider T Mucosal Immunol; 2016 Jan; 9(1):265-74. PubMed ID: 26129649 [TBL] [Abstract][Full Text] [Related]
2. Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients. Kök A; Hocqueloux L; Hocini H; Carrière M; Lefrou L; Guguin A; Tisserand P; Bonnabau H; Avettand-Fenoel V; Prazuck T; Katsahian S; Gaulard P; Thiébaut R; Lévy Y; Hüe S Mucosal Immunol; 2015 Jan; 8(1):127-40. PubMed ID: 24985081 [TBL] [Abstract][Full Text] [Related]
3. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. Mavigner M; Cazabat M; Dubois M; L'Faqihi FE; Requena M; Pasquier C; Klopp P; Amar J; Alric L; Barange K; Vinel JP; Marchou B; Massip P; Izopet J; Delobel P J Clin Invest; 2012 Jan; 122(1):62-9. PubMed ID: 22156200 [TBL] [Abstract][Full Text] [Related]
4. Antiretroviral Therapy in Primary HIV-1 Infection: Influences on Immune Activation and Gut Mucosal Barrier Dysfunction. Cao W; Mehraj V; Vyboh K; Li T; Routy JP AIDS Rev; 2015; 17(3):135-46. PubMed ID: 26450802 [TBL] [Abstract][Full Text] [Related]
5. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895 [TBL] [Abstract][Full Text] [Related]
6. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. Schuetz A; Deleage C; Sereti I; Rerknimitr R; Phanuphak N; Phuang-Ngern Y; Estes JD; Sandler NG; Sukhumvittaya S; Marovich M; Jongrakthaitae S; Akapirat S; Fletscher JL; Kroon E; Dewar R; Trichavaroj R; Chomchey N; Douek DC; O Connell RJ; Ngauy V; Robb ML; Phanuphak P; Michael NL; Excler JL; Kim JH; de Souza MS; Ananworanich J; PLoS Pathog; 2014 Dec; 10(12):e1004543. PubMed ID: 25503054 [TBL] [Abstract][Full Text] [Related]
7. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial. d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778 [TBL] [Abstract][Full Text] [Related]
8. Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques. O'Connor MA; Munson PV; Tunggal HC; Hajari N; Lewis TB; Bratt D; Moats C; Smedley J; Bagley KC; Mullins JI; Fuller DH AIDS Res Hum Retroviruses; 2019 Mar; 35(3):295-305. PubMed ID: 30398361 [TBL] [Abstract][Full Text] [Related]
9. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status. Critchfield JW; Young DH; Hayes TL; Braun JV; Garcia JC; Pollard RB; Shacklett BL PLoS One; 2008; 3(10):e3577. PubMed ID: 18974782 [TBL] [Abstract][Full Text] [Related]
10. Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers. Kim CJ; Rousseau R; Huibner S; Kovacs C; Benko E; Shahabi K; Kandel G; Ostrowski M; Kaul R AIDS; 2017 Jul; 31(11):1529-1534. PubMed ID: 28463882 [TBL] [Abstract][Full Text] [Related]
11. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy. Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968 [TBL] [Abstract][Full Text] [Related]
12. CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors. Ciccone EJ; Greenwald JH; Lee PI; Biancotto A; Read SW; Yao MA; Hodge JN; Thompson WL; Kovacs SB; Chairez CL; Migueles SA; Kovacs JA; Margolis LB; Sereti I J Virol; 2011 Jun; 85(12):5880-8. PubMed ID: 21471231 [TBL] [Abstract][Full Text] [Related]
13. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials. Kim CJ; Walmsley SL; Raboud JM; Kovacs C; Coburn B; Rousseau R; Reinhard R; Rosenes R; Kaul R HIV Clin Trials; 2016 Jul; 17(4):147-57. PubMed ID: 27267710 [TBL] [Abstract][Full Text] [Related]
14. Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals. Gordon SN; Cervasi B; Odorizzi P; Silverman R; Aberra F; Ginsberg G; Estes JD; Paiardini M; Frank I; Silvestri G J Immunol; 2010 Nov; 185(9):5169-79. PubMed ID: 20889546 [TBL] [Abstract][Full Text] [Related]
15. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. Mehandru S; Poles MA; Tenner-Racz K; Jean-Pierre P; Manuelli V; Lopez P; Shet A; Low A; Mohri H; Boden D; Racz P; Markowitz M PLoS Med; 2006 Dec; 3(12):e484. PubMed ID: 17147468 [TBL] [Abstract][Full Text] [Related]
16. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration. George MD; Reay E; Sankaran S; Dandekar S J Virol; 2005 Mar; 79(5):2709-19. PubMed ID: 15708990 [TBL] [Abstract][Full Text] [Related]
17. CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals. Loiseau C; Requena M; Mavigner M; Cazabat M; Carrere N; Suc B; Barange K; Alric L; Marchou B; Massip P; Izopet J; Delobel P Mucosal Immunol; 2016 Sep; 9(5):1137-50. PubMed ID: 26883727 [TBL] [Abstract][Full Text] [Related]
18. Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection. de Paula HHS; Ferreira ACG; Caetano DG; Delatorre E; Teixeira SLM; Coelho LE; João EG; de Andrade MM; Cardoso SW; Grinsztejn B; Veloso VG; Morgado MG; Guimarães ML; Côrtes FH Retrovirology; 2018 Dec; 15(1):76. PubMed ID: 30541557 [TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity? Costiniuk CT; Angel JB Mucosal Immunol; 2012 Nov; 5(6):596-604. PubMed ID: 22929559 [TBL] [Abstract][Full Text] [Related]